CD276 and neoplasm: Furthermore, CD276 is overexpressed on several other tumors—such as pancreatic ductal adenocarcinoma (PDAC), prostate cancer, ovarian cancer, lung cancer, and clear cell renal carcinoma—and on tumor-associated vasculature and stroma fibroblasts [73,75,76,77,78,79,80,81,82,83,84,85].